VivoSim Labs, Inc. (NASDAQ: VIVS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT VIVOSIM LABS, INC.

VivoSim Labs, Inc. (NASDAQ: VIVS)
Listen to this Section


$1.26
-0.0200 ( -1.56% ) 32.3K

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Market Data


Open $1.26
Previous Close $1.28
Volume 32.3K
Market Cap $3.70M
Day Range $1.26 - $1.32
52 Week Range $1.22 - $5.30
Shares Outstanding 2.89M
Change % -1.56%
Net Change ▼ -0.0200
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
IPO Year2011
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
def Proxies and info statements 22 Nov 03, 2025

Latest News


× Before browsing our site, please accept our cookies policy